Cargando…
Ligandrol (LGD-4033)-Induced Liver Injury
We described a 32-year-old man who developed severe drug-induced liver injury after using Ligandrol (LGD-4033). The diagnosis was confirmed by a liver biopsy that showed cholestatic hepatitis with a mild portal, periportal, and perisinusoidal fibrosis. Ligandrol is a selective androgen receptor modu...
Autores principales: | Barbara, Mary, Dhingra, Sadhna, Mindikoglu, Ayse L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304490/ https://www.ncbi.nlm.nih.gov/pubmed/32637435 http://dx.doi.org/10.14309/crj.0000000000000370 |
Ejemplares similares
-
Drug-Induced Liver Injury Associated With Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033)
por: Barbara, Mary, et al.
Publicado: (2020) -
Variation of Sequential Ligandrol (LGD-4033) Metabolite Levels in Routine Anti-Doping Urine Samples Detected with or without Other Xenobiotics
por: Kwiatkowska, Dorota, et al.
Publicado: (2023) -
Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes
por: Wagener, Felicitas, et al.
Publicado: (2021) -
Investigations into the concentration and metabolite profiles of stanozolol and LGD-4033 in blood plasma and seminal fluid using liquid chromatography high-resolution mass spectrometry
por: Breuer, Johanna, et al.
Publicado: (2022) -
Ostarine and Ligandrol Improve Muscle Tissue in an Ovariectomized Rat Model
por: Roch, Paul Jonathan, et al.
Publicado: (2020)